Meta-Analysis
Copyright ©The Author(s) 2022.
World J Clin Cases. Jun 16, 2022; 10(17): 5690-5701
Published online Jun 16, 2022. doi: 10.12998/wjcc.v10.i17.5690
Table 2 Basic characteristics table
Ref.
Intervention measure
Control measure
Average age (yr)
Duration of treatment/follow-up (wk)
Experimental group
Control group
Zhang et al[15], 2008Yougui pills + levothyroxine sodiumLevothyroxine sodium53558
Li et al[16], 2012Yougui pills + levothyroxine sodiumLevothyroxine sodium68.1 ± 5.366.7 ± 5.112
Zhang et al[17], 2015Yougui pills + levothyroxine sodiumLevothyroxine sodium42.7 ± 3.642.7 ± 3.6
Li et al[18], 2016Yougui pills + levothyroxine sodiumLevothyroxine sodium40.2 ± 9.440.2 ± 9.4
Wang et al[19], 2016Yougui pills + levothyroxine sodiumLevothyroxine sodium40.12 ± 9.5040.57 ± 9.5312
Jiang et al[20], 2017Yougui pills + levothyroxine sodiumLevothyroxine sodium40.9 ± 5.640.8 ± 5.812
Liu et al[21], 2017Yougui pills + levothyroxine sodiumLevothyroxine sodium37.98 ± 13.8338.88 ± 12.108
Chen et al[22], 2018Yougui pills + levothyroxine sodiumLevothyroxine sodium40.88 ± 5.1240.95 ± 5.6212
Shi et al[23], 2018Yougui pills + levothyroxine sodiumLevothyroxine sodium44.6 ± 12.445.1 ± 11.912